Screening for cystic fibrosis and its evaluation

British Medical Bulletin

Volumn 54, Issue 4, 1998, Pages 857-875

  Wildhagen, Mark F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; EARLY DIAGNOSIS; FETUS; GENETIC COUNSELING; HUMAN; NEWBORN; PRENATAL SCREENING; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0032439769     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011734     Document Type: Review

References (20)

1. Anonymous. Genetic testing for cystic fibrosis. NIH Consensus Statement Online 1997; 15: 1-34
2. Fanconi G, Uehlinger E, Knauer C. Das Coeliakiesyndrom bei angeborener zysticher Pankreasfibromatose und Bronchiektasien. Wien Med Wochenschr 1936; 86: 753-6
3. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am }Dis Child 1938; 56: 344-99
4. Welsh MJ, Tsui LC, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease, vol 3: 7th edn. New York: McGraw-Hill, 1995; 3799-876
5. Rosenstein BJ, Zeitlin PL. Cystic fibrosis [review]. Lancet 1998; 351: 277-82
6. Wildhagen MF, Verheij JBGM, Verzijl JG et al. Cost of care of patients with cystic fibrosis in The Netherlands in 1990-1. Thorax 1996; 51: 298-301
7. Wildhagen MF, Verheij JBGM, Verzijl JG et al. The nonhospital costs of care of patients with CF in The Netherlands: results of a questionnaire. Eur Respir ] 1996; 9: 2215-9
8. Ornoy A, Arnon J, Katznelson D et al. Pathological confirmation of cystic fibrosis in the fetus following prenatal diagnosis. Am J Med Genet 1987; 28: 935-47
9. Brugman SM, Taussig LM. The reproductive system. In: Taussig L. (ed) Cystic fibrosis. New York: Thieme Stratton, 1984: 323-37
10. Buchwald M. Cystic fibrosis: from the gene to the dream. Clin Invest Med 1996; 19: 304-10
11. Aitken ML, Burke \V, McDonald G et al. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. JAMA 1992; 267: 1947-51
12. Mylett J, Johnson K, Knowles M. Alternate therapies for cystic fibrosis. Semin Respir Crit Care Med 1994; 15: 426-33
13. Tamm M, Higenbottam T. Heart-lung and lung transplantation for cystic fibrosis: world experience. Semin Respir Crit Care Med 1994; 15: 414-25
14. Wilson JM. Cystic fibrosis: strategies for gene therapy. Semin Respir Crit Care Med 1994; 15: 439-5
15. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991; 46: 881-5
16. Blythe SA, Farrell PM. Advances in the diagnosis and management of cystic fibrosis. Clin Biochem 1984; 17: 277-83
17. Wright SW, Morton NE. Genetic studies on cystic fibrosis in Hawaii. Am J Hunt Genet 1968; 20: 157-68
18. Roberts G, Stanfield M, Black A, Redmond A. Screening for cystic fibrosis: a four year regional experience. Arch Dis Child 1988; 63: 1438-43
19. Ten Kate LP. Cystic fibrosis in The Netherlands, bit] Epidemiol 1977; 6: 23-34
20. De Vries HG, Collee JM, de Walle HE et al. Prevalence of delta F508 cystic fibrosis carriers in The Netherlands: logistic regression on sex, age, region of residence and number of offspring. Hum Genet 1997; 99: 74-9